Kochi, India

Ullas Mony


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ullas Mony: Innovator in Hemostatic Agents

Introduction

Ullas Mony is a notable inventor based in Kochi, India. He has made significant contributions to the field of medical innovations, particularly in the development of hemostatic agents. His work focuses on creating effective solutions for controlling bleeding in various medical scenarios.

Latest Patents

Ullas Mony holds a patent for a hemostatic agent and method of production thereof. This innovative composition is designed for rapid and effective hemostasis. The formulation includes a first agent to induce platelet plug formation, a second agent to induce vasoconstriction, and a third agent for the activation of the coagulation cascade. The composition comprises 0.01% to 5% of chitosan, 0.01% to 0.25% of potassium aluminum sulfate, and 0.01% to 0.25% of calcium salt. The clotting time of this composition ranges from 30 seconds to 140 seconds. Additionally, a method for preparing this hemostatic composition is disclosed, which is configured to control hemorrhage from oozing and pressured bleeding injuries at any site in the human or animal body.

Career Highlights

Ullas Mony is associated with Amrita Vishwa Vidyapeetham, where he continues to contribute to research and development in the medical field. His innovative approach and dedication to improving medical solutions have made him a valuable asset in his field.

Collaborations

Ullas has collaborated with notable colleagues such as Jayakumar Rangasamy and Nivedhitha Muthiah Pillai Sundaram. These collaborations have further enhanced his research and development efforts in creating effective medical solutions.

Conclusion

Ullas Mony's contributions to the field of hemostatic agents demonstrate his commitment to advancing medical technology. His innovative patent reflects a significant step forward in controlling bleeding, which can have a profound impact on patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…